title: Evidence that oral pentoxifylline reverses acute renal dysfunction in bone marrow transplant recipients receiving amphotericin B and cyclosporine. Results of a pilot study.
authors.affiliation: Division of Oncology Clinical Research, Veterans Affairs Medical Center, Seattle, Washington 98108.
authors.forename: J A
authors.initials: JA
authors.lastname: Bianco
authors.forename: J
authors.initials: J
authors.lastname: Almgren
authors.forename: D L
authors.initials: DL
authors.lastname: Kern
authors.forename: B
authors.initials: B
authors.lastname: Ballard
authors.forename: K
authors.initials: K
authors.lastname: Roark
authors.forename: F
authors.initials: F
authors.lastname: Andrews
authors.forename: J
authors.initials: J
authors.lastname: Nemunaitis
authors.forename: T
authors.initials: T
authors.lastname: Shields
authors.forename: J W
authors.initials: JW
authors.lastname: Singer
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation / Q000009:adverse effects; D003524:Cyclosporins / Q000627:therapeutic use*; D006801:Humans; D007674:Kidney Diseases / Q000188:drug therapy* / Q000209:etiology; D010431:Pentoxifylline / Q000008:administration & dosage*; D010865:Pilot Projects; D011446:Prospective Studies; D014184:Transplantation, Homologous / Q000706:statistics & numerical data
chemical_list: D003524:Cyclosporins; D000666:Amphotericin B; D010431:Pentoxifylline